In patients with SLE, early endothelial dysfunction is present in those subjects who have low FMD, which correlates with modified or native LDL, as well as soluble E-selectin and ICAM-1 serum levels [25,28]. This evidence concerns the gene ICAM1 and systemic lupus erythematosus.